Stocks · Health care · Pharmaceutical Preparations

Roivant Sciences Ltd.

ROIV Clue Score19
Bermuda Fiscal year ends March CIK 0001635088 Results filed 6 Aug 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Eric Venker
3 Nov 2026
President & Immunovant CEO
Sold on a plan
200,000
$36.31
$7.26M
Eric Venker
28 Oct 2026
President & Immunovant CEO
Sold on a plan
200,000
$36.59
$7.32M
Eric Venker
20 Oct 2026
President & Immunovant CEO
Sold on a plan
14,144
$35.42
$500.98K
Eric Venker
20 Oct 2026
President & Immunovant CEO
Sold on a plan
185,856
$35.09
$6.52M

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 56,513
History held since 17 Oct 2017